“A REVIEW ON THE PHARMACEUTICAL ANALYTICAL PROFILE OF AN ANTIVIRAL DRUG: REMDESIVIR” (2022) Journal of Pharmaceutical Negative Results, pp. 217–225. doi:10.47750/pnr.2022.13.S09.026.